APA (7th ed.) Citation

GW, K., DH, L., J, Y., YH, J., SW, L., SY, O., & SH, K. (2025). Histone demethylase KDM4C confers temozolomide resistance to glioblastoma cells by epigenetically regulating E2F6. Archives of pharmacal research, 48(11-12), 1345. https://doi.org/10.1007/s12272-025-01580-y

Chicago Style (17th ed.) Citation

GW, Kim, Lee DH, Yoo J, Jeon YH, Lee SW, Oh SY, and Kwon SH. "Histone Demethylase KDM4C Confers Temozolomide Resistance to Glioblastoma Cells by Epigenetically Regulating E2F6." Archives of Pharmacal Research 48, no. 11-12 (2025): 1345. https://doi.org/10.1007/s12272-025-01580-y.

MLA (9th ed.) Citation

GW, Kim, et al. "Histone Demethylase KDM4C Confers Temozolomide Resistance to Glioblastoma Cells by Epigenetically Regulating E2F6." Archives of Pharmacal Research, vol. 48, no. 11-12, 2025, p. 1345, https://doi.org/10.1007/s12272-025-01580-y.